Want to join the conversation?
$ABBV 2Q15 Call: Earlier this year, we entered into collaboration with C2N Diagnostics to develop and commercialize a portfolio of anti-tau antibodies. We recently received an Orphan Drug Designation for HUMIRA and initiated a phase I program. We are on track to start clinical development with C2N in Alzheimer’s disease in 2016.
Vine, the unique app from $TWTR is no more! Perfect example for mass products that don't make money!
$CVX posts first profit in a year. Right time to get some shares? My question is, will it sustain this turnaround?
Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?
Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein